Congratulations Jacinta

We are delighted to announce that Jacinta Marron has been appointed to the newly created post of Head of Biometrics at Cancer Trials Ireland. As Head of Biometrics, Jacinta will lead the Biometrics unit of Data Management and Statistics in collaboration with Group Statistician, Imelda Parker. Jacinta joined Cancer Trials Ireland in 2015 and has […]

JAVELIN Head & Neck 100

The JAVELIN Head & Neck 100 trial is the first of its kind to open in Ireland. It increases treatment opportunities for some Irish patients. It is a Phase III double-blind randomised controlled trial (RCT) studying the effect of avelumab, versus placebo, in combination with standard of care CRT in the frontline treatment of patients […]

Publications update

Here’s a list of the 14 publications in academic peer reviewed journals since the last DSSG Digest (Spring) in which Cancer Trials Ireland investigators participated. If you would like your publications included in our next listing please contact Compiled by Dr Orla Casey, Translational Project Manager, Cancer Trials Ireland Publications update

DSSG Autumn 2018

At our Autumn DSSG /Scientific meeting, which coincided with the 2018 Gathering Around Cancer hosted at Croke Park, the GU Cancer Research meeting welcomed our new patient consultant Eddie MacEoin (left). Pictured with Eddie is Eibhlin Mulroe, CEO of Cancer Trials Ireland, and Jonathon Westrup, Chair of the Board of Cancer Trials Ireland. Also pictured […]


Pictured at Cancer Trials Ireland’s AGM at Croke Park which coincided with the 2019 Gathering Around Cancer and the organisation’s Autumn Scientific meeting were (l to r) Board members Dr Linda Coate, Vice Clinical Lead, Cancer Trials Ireland; Dr Rob O’Connor, Head of Research, Irish Cancer Society; Dr Jonathan Westrup, Chair of the Board; Dr […]